Table 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx
Objective<p>Silicosis is characterized by silicon nodules and diffuse pulmonary fibrosis. To date, no effective therapy has been developed for the treatment of silicosis. This study aimed to investigate the effects of Galunisertib, a TGF-β receptor I kinase inhibitor, on the autophagy-lysosome...
Na minha lista:
| Autor principal: | Rou Li (11575418) (author) |
|---|---|
| Outros Autores: | Huimin Kang (435951) (author), Aoxiang Hu (22679153) (author), Guo Chen (182090) (author), Tinghua Yan (18786622) (author), Ting Liu (45625) (author), Shi Chen (120917) (author) |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
-
Table 1_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.xlsx
Por: Rou Li (11575418)
Publicado em: (2025) -
Image 1_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.tif
Por: Rou Li (11575418)
Publicado em: (2025) -
Image 2_Galunisertib attenuates pulmonary fibrosis with silicosis in mouse via TGF-β/TRAF6/Beclin1 signaling pathway.tif
Por: Rou Li (11575418)
Publicado em: (2025) -
Image 13_The role of TMEM59L in colorectal cancer progression and its interaction with the TGF-β/Smad pathway.jpeg
Por: Hongjie Yang (383059)
Publicado em: (2025) -
Image 14_The role of TMEM59L in colorectal cancer progression and its interaction with the TGF-β/Smad pathway.jpeg
Por: Hongjie Yang (383059)
Publicado em: (2025)